Physician profile
Maxwell S Cosmic
NPI 1164408548
$3,367.30
in general payments reported to CMS, 2019-2025
18 companies · $954 in 2025
The $954 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.82 · 2020: $16.24 · 2021: $279 · 2022: $128 · 2023: $1,588 · 2024: $386 · 2025: $954.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,928.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,927.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $1,205.31 | 2021-2025 | Tyvaso, Remodulin |
| Actelion Pharmaceuticals US, INC. | $1,130.83 | 2021-2024 | Uptravi, Opsumit |
| Genzyme Corporation | $178.65 | 2025 | |
| La Jolla Pharmaceutical Company | $158.83 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $149.71 | 2023-2025 | Ofev, Jascayd |
| Merck Sharp & Dohme LLC | $125.77 | 2025 | Winrevair |
| Verona Pharma, INC. | $121.13 | 2025 | Ohtuvayre |
| Grifols USA, LLC | $95.03 | 2025 | Prolastin-C Liquid |
| Amgen INC. | $48.26 | 2025 | Tezspire |
| Insmed, INC. | $30.43 | 2020-2025 | Arikayce |
| Regeneron Healthcare Solutions, INC. | $24.73 | 2025 | Dupixent |
| Baxter Healthcare | $24.02 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Glaxosmithkline, LLC. | $22.65 | 2025 | Nucala |
| Abiomed | $20.57 | 2023 | Impella |
| Csl Behring | $16.82 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electromed, INC. | $14.56 | 2024 | Smartvest |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maxwell Cosmic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.